Tower Research Capital LLC (Trc) Bio Atla, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Bio Atla, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 23,316 shares of BCAB stock, worth $8,626. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,316Holding current value
$8,626% of portfolio
0.0%Shares
17 transactions
Others Institutions Holding BCAB
# of Institutions
41Shares Held
13.4MCall Options Held
20.7KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.84MShares$1.79 Million1.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.78MShares$659,7640.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.49MShares$552,2440.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.37MShares$508,4080.03% of portfolio
-
Black Rock Inc. New York, NY792KShares$292,8770.0% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $13.4M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...